AQR Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$322K Sell
2014
Q4
$1.82M Buy
2014
Q3
$1.02M Buy
2014
Q2
$776K Buy
2014
Q1
$465K Buy
2013
Q4
Sell
2013
Q3
$3.28M Buy
2013
Q2
$462K Buy